Analyst tracks

David Steinberg will join Jefferiesas a managing director and specialty pharmaceuticals analyst, starting in January. Steinberg is leaving Deutsche Bank, where he had been a managing director and specialty pharmaceuticals analyst.

William Tanner joined FBR Capital Markets & Co. as a managing director and initiated coverage of 16 companies, including hypercholesterolemia play Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR), biotech bellwether Biogen Idec Inc. (NASDAQ:BIIB) and microRNA company Regulus Therapeutics Inc. (NASDAQ:RGLS). Tanner was a managing director at Lazard Capital Markets...